{"basic_info": {"ticker": "2252", "exchange": "XSHE", "bloomberg_ticker": "002252 CH Equity", "name": "SHANGHAI RAAS BLOOD PRODUC-A", "industry": "Biotechnology", "name_chinese_simplified": "上海莱士", "period": "2020", "market_value": 48803303424, "total_income": 1309311248, "ccy": "人民币元", "shariah_compliance_summary": "compliant"}, "business_activity_screening": {"summary": [{"shariah_compliance": "compliant", "income": 1309139881, "business_income_over_total_income": 0.9998691166823306}, {"shariah_compliance": "unknown", "income": 171366, "business_income_over_total_income": 0.00013088255390898468}], "details": [{"business_activity_cn": "人血白蛋白", "business_activity_en": "Human serum albumin", "income": 395699716, "business_income_over_total_income": 0.30221974843983007, "shariah_compliance": "compliant"}, {"business_activity_cn": "静注人免疫球蛋白", "business_activity_en": "Intravenous human immunoglobulin", "income": 553213043, "business_income_over_total_income": 0.4225221801500937, "shariah_compliance": "compliant"}, {"business_activity_cn": "其他血液制品", "business_activity_en": "Other blood products", "income": 360227122, "business_income_over_total_income": 0.2751271880924069, "shariah_compliance": "compliant"}, {"business_activity_cn": "其他业务", "business_activity_en": "Other business", "income": 171366, "business_income_over_total_income": 0.00013088255390898468, "shariah_compliance": "unknown"}]}, "financial_screening": [{"item": "Debt to Market Capitalization", "amount": 3.411655044769924e-05, "shariah_compliance": "compliant", "amount_over_market_value": 3.411655044769924e-05}]}